Elchanan Quint

Dr. Elchanan Quint

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2025 in Current Problems in Surgery
Verified
Journal Article
Open access
IKIvan Kukeev
Ivan Kukeev
YAYuval Arnon
Yuval Arnon
EQElchanan Quint
Elchanan Quint
AOAnton Osyntsov
Anton Osyntsov
ODOleg Dukhno
Oleg Dukhno

24 May 2023 in Canadian Journal Of Surgery
Verified
Journal Article
Open access
PDF file
EQElchanan Quint
Elchanan Quint
IKIvan Kukeev
Ivan Kukeev
IHItai Hazan
Itai Hazan
DGDaniel Grupel
Daniel Grupel
ODOleg Dukhno
Oleg Dukhno
DCDavid Czeiger
David Czeiger
Background: In a large nationwide mass vaccination setting, the SARS-CoV-2 vaccine was recently linked to myocarditis, lymphadenopathy, herpes zoster infection and appendicitis. We aimed to examine the characteristics and management of SARS-CoV-2 vaccine-related acute appendicitis. Methods: We performed a retrospective cohort study in a large tertiary medical centre in Israel. All patients presenting with acute appendicitis within 21 days of receiving their SARS-CoV-2 vaccination (PCVAA group) were compared with patients who presented with acute appendicitis not related to the vaccination (N-PCVAA group). Results: We reviewed the records of 421 patients with acute appendicitis from December 2020 to September 2021; 38 (9%) patients presented with acute appendicitis within 21 days of receiving their SARS-CoV-2 vaccination. Patients in the PCVAA group were older than those in the N-PCVAA group (mean 41 ± 19 yr v. 33 ± 15 yr, respectively, p = 0.008), with male predominance. More patients were managed nonsurgically during the pandemic than before the pandemic (24% v. 18%, p = 0.03). Conclusion: With the exception of older age, the clinical characteristics of patients presenting with acute appendicitis within 21 days of receiving the SARS-CoV-2 vaccination did not differ from those of patients who presented with acute appendicitis not related to the vaccination. This finding suggests that vaccine-related acute appendicitis is similar to “classic” acute appendicitis. Contexte: Dans le contexte d’une campagne nationale de vaccination de masse, le vaccin anti-SRAS-CoV-2 a récemment été associé à des cas de myocardite, de lymphadénopathie, de zona et d’appendicite. Nous avons voulu examiner les caractéristiques et la prise en charge de l’appendicite aiguë liée au vaccin anti-SRAS-CoV-2. Méthodes: Nous avons procédé à une étude de cohorte rétrospective dans un grand centre médical de soins tertiaires d’Israël. Tous les patients ayant consulté pour appendicite aiguë dans les 21 jours suivant une vaccination anti-SRAS-CoV-2 (groupe PCVAA) ont été comparés à ceux qui ont consulté pour appendicite aiguë indépendamment de la vaccination (groupe N-PCVAA). Résultats: Nous avons passé en revue les dossiers de 421 personnes ayant présenté une appendicite aiguë entre décembre 2020 et septembre 2021; 38 (9 %) malades ont consulté pour appendicite aiguë dans les 21 jours suivant leur vaccination anti-SRAS-CoV-2. Les malades du groupe PCVAA étaient plus âgés que ceux du groupe N-PCVAA (âge moyen 41 ± 19 ans c. 33 ± 15 ans, respectivement, p = 0,008), et majoritairement de sexe masculin. Un plus grand nombre de malades ont été traités non chirurgicalement pendant que avant la pandémie (24 % c. 18 %, p = 0,03). Conclusion: À l’exception de l’âge avancé, les caractéristiques cliniques des malades souffrant d’une appendicite aiguë dans les 21 jours suivant leur vaccination anti-SRAS-CoV-2 n’ont pas différé de celles des malades ayant présenté une appendicite aiguë non associée à la vaccination. Selon cette observation, l’appendicite aiguë liée à la vaccination est similaire à l’appendicite aiguë « classique ».

2 May 2024 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
IKIvan Kukeev
Ivan Kukeev
EQElchanan Quint
Elchanan Quint
GSGilbert Sebbag
Gilbert Sebbag
ODOleg Dukhno
Oleg Dukhno
Laparoscopic one-anastomosis gastric bypass (LOAGB) has gained popularity as safe weight-reduction procedure. Bleeding is the common postoperative complication. We present a successful treatment of recurrent bleeding after LOAGB by embolization of the left gastric artery (LGA) and later development of necrotizing pancreatitis. A 41-year-old patient with previous bariatric surgeries undergone LOAGB surgery with development of massive intraluminal bleeding in the postoperative period. Attempts of unsuccessful endoscopic treatment were done and the bleeding was stopped by LGA embolization. In the post-embolization period, the patients developed necrotizing pancreatitis. Postoperative bleeding is the serious complications of the bariatric LOAGB procedure. Transcatheter Arterial Embolization (TAE) is the possible treatments after unsuccessful endoscopic attempts to stop the bleeding. The technical and clinical success rates of TAE in post-gastrectomy bleeding are 100 and 79%, respectively. TAE can be successfully used to stop obstinate recurrent postoperative bleeding after a LOAGB procedure.

4 November 2026 in International Journal of Surgery
Verified
Journal Article
Open access
NANur Alkrinawi
Nur Alkrinawi
SFSofyan Abu Freih
Sofyan Abu Freih
YAYuval Arnon
Yuval Arnon
ASAbu-Swis Shadi
Abu-Swis Shadi
AVAlex Vakhrushev
Alex Vakhrushev
ODOleg Dukhno
Oleg Dukhno
Background: The prevalence of patients with extreme obesity [body mass index (BMI) ≥ 50] has significantly increased over the past three decades, surpassing the rise in the prevalence of overweight individuals in the general population. Ring-augmented one-anastomosis gastric bypass (RA-OAGB) is a modification of standard one-anastomosis gastric bypass (OAGB) designed to enhance the durability of long-term weight-loss and potentially reduce pouch dilation, particularly in patients with extreme obesity. While short-term outcomes appear comparable to other procedures, long-term comparative data remain limited. Methods: In this retrospective single-center study, we compared patients who underwent RA-OAGB with those who underwent OAGB or sleeve gastrectomy (SG) procedures, all with a minimum follow-up of ≥5 years. Data collected included demographics, comorbidities, perioperative outcomes, long-term complications, and patient-reported quality of life. Results: A total of 111 patients were included in our study during the study period – 24 underwent RA-OAGB, 44 OAGB, and 43 SG. Loss to direct follow-up at 5 years was 15% (94/111 patients had direct follow-up), although clinical data were available for all patients through medical records. The RA-OAGB group had a higher baseline BMI than the OAGB and SG groups (55.4 vs. 51.2 and 51.3 kg/m 2 ; P = 0.006). In the unadjusted analysis, median percentage of excess weight loss (%EWL) was 74%, 63%, and 52%, respectively ( P = 0.027), while median percentage of total weight loss (%TWL) was 42.4%, 37.5%, and 28.9%, respectively ( P = 0.017). After adjustment for baseline BMI and follow-up duration, BMI was significantly lower after RA-OAGB compared with SG ( P = 0.025); RA-OAGB remained associated with greater %EWL ( P = 0.001) and %TWL ( P = 0.002) compared with SG. Adjusted associations with symptomatic gastroesophageal reflux disease (GERD) were not statistically significant. Iron-deficiency anemia was more frequent after bypass procedures than after SG. Quality of life and patient satisfaction were high across all groups, with no significant differences in Bariatric Analysis and Reporting Outcome System (BAROS) scores. Conclusion: In this retrospective single-center study, RA-OAGB was associated with greater long-term weight loss than OAGB and SG. However, given the observational design, baseline differences between groups, and limited sample size, these findings should be considered hypothesis-generating and require confirmation in larger prospective multicenter studies.

14 September 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
EQElchanan Quint
Elchanan Quint
LSLior Segev
Lior Segev
VGVladimir Gaziants
Vladimir Gaziants
UNUri Netz
Uri Netz
ARAvi Reshef
Avi Reshef
CKCharles Knowles
Charles Knowles
Background: Morbidity associated with anastomotic leak (AL) can be reduced by timely detection. Local electrophysiological parameters are highly sensitive to pathophysiological processes (inflammation/ischemia) underlying AL and may enable early post-op monitoring ahead of clinical signs. A new approach to early leak detection includes post-operative measurement of bioelectric activity of the GI tract. The method has been implemented in a medical device that uses electrodes embedded in a standard surgical drain to continuously monitor local bowel myoelectric activity following GI surgery. Methods: A multicenter pilot study evaluated the performance of the device to support detection of clinically recognizable anastomotic leaks on post-operative day 3. The device’s technology collected data that an algorithm classified to predict AL. Data were collected for a duration of 3–10 days, while the surgical drain was in place (without affecting routine care). Pilot endpoints were safety and performance analyses: sensitivity and specificity. Results: Fifty patients from 6 medical centers (mean age: 63.6 ± 13.3 years; 38% male) undergoing elective anterior resection (laparoscopic (N = 26), robotic (N = 16), open (N = 8)) for cancer (N = 44), diverticulitis (N = 4), and rectal prolapse (N = 2) were included. Average anastomotic height was 9 ± 5 cm from the anal verge. Grade C ALs were observed in 6.0% (N = 3) of the patients, resulting in increased hospitalization time (6.4 ± 2.4 days with no leak vs. 15.0 ± 7.9 days with Grade C leak). In this N = 50 cohort, the device had 100% sensitivity and 100% specificity at POD3 in prediction of Grade C leaks. Given the small number of events (three Grade C leaks, seven leaks overall), these results are preliminary. No device-related serious adverse events were observed, and the standard drain form factor contributed to positive usability feedback. Conclusions: Pilot data suggest that the bioelectric sensing drain device is safe and warrants further evaluation as a potential adjunct for AL detection. The small study sample size and wide confidence intervals for key outcomes require confirmation in a pivotal diagnostic accuracy study with a fixed thresholding algorithm.